OPINION and ORDER
This is a suit for monetary and injunc-tive relief filed by the State of Wisconsin against twenty pharmaceutical manufacturers. Plaintiff alleges that defendants inflated the average wholesale prices of their drugs, thereby violating several provisions of Wisconsin law. The case was originally filed in the Circuit Court for Dane County. On July 14, 2004, defendant Bayer Corporation filed a notice of removal with this court, asserting that this court had jurisdiction over this case under the diversity statute, 28 U.S.C. § 1332. All of the other defendants filed consents to the removal, with the exception of defendant Gensia Sicor Pharmaceuticals, Inc., which did not file its consent until July 27, 2004, one day after plaintiff filed its motion to remand. In its motion, plaintiff also requested an award of costs and attorney fees incurred as a result of the removal. In an order dated September 9, 2004, I lifted a previously entered stay on the briefing regarding plaintiffs motion to remand. Defendants have submitted a brief in opposition and I am ready to rule on plaintiffs motion. After reviewing the arguments submitted by the parties, I conclude that removal of this case was improper because this court lacks subject matter jurisdiction over the case. Therefore, I will grant plaintiffs motion to remand. In addition, I will grant plaintiffs request for costs and attorney fees.
FACTS
Plaintiff State of Wisconsin, through its Attorney General Peggy A. Lautenschlager, filed its complaint in the Circuit Court for Dane County, Wisconsin, on June 3, 2004. Plaintiffs complaint consists of five counts arising from defendants’ alleged practice of “publishing false and inflated prices for their drugs.” Cpt. ¶ 1. Plaintiff brought this action “on behalf of itself, its citizens, and Wisconsin organizations (those that pay the prescription drug costs of their members, hereinafter ‘private payers’), who have paid inflated prices for defendants’ prescription drugs as a result of defendants’ unlawful conduct.” Cpt. ¶ 2.
Plaintiff alleges that defendants’ alleged inflation of drug prices caused harm to the state, Wisconsin citizens, and certain private, Wisconsin-based organizations. First, plaintiff alleges that defendants’ conduct caused the state to overpay for the drugs it purchases through its Medicaid program. Second, plaintiff alleges that Wisconsin Medicare Part B participants, primarily disabled and elderly citizens, were forced to pay higher co-pays for their prescription drugs than they would if defendаnts had published the actual drug prices. Third, plaintiff alleges that private, Wisconsin-based organizations that pay the prescription drug costs of their members overpaid for prescription drugs. Cpt. ¶ 52.
The complaint consists of five counts, all arising under Wisconsin law. Counts I and II allege violations of Wis. Stat. §§ 100.18(1) and 100.18(10)(b), which prohibit making false reрresentations with the intent to sell merchandise. Count III alleges a violation of the Wisconsin Trust and Monopolies Act, Wis. Stat. § 133.05. Count IV alleges a claim for fraud on the Wisconsin Medicaid Program, Wis. Stat. § 49.49(4m)(a)(2). Count V states a common law claim for unjust enrichment.
Plaintiff seeks several forms of relief. With respect to Counts I and II, plaintiff seeks injunctive relief, civil forfeitures and restitution to the state programs, private *1060 citizens, and other private payers harmed by defendants’ actions. On Count III, plaintiff seeks injunctive relief, civil forfeitures and treble damages for the state and those injured by defendants’ conduct. With respect to Count IV, plaintiff seeks civil forfeitures and remedial damages. For Count V, plaintiff seeks injunctive relief and disgorgement of all profits realized as a result of defendants’ unlawful conduct.
DISCUSSION
A. Jurisdiction
Initially, I note that on August 3, 2004, the Clerk of the Judicial Panel on Multi-district Litigation issued a conditional transfer order transferring this case to the District of Massachusetts for consolidated pre-trial proceеdings pursuant to 28 U.S.C. § 1407. However, Rule 1.5 of the Rules of Procedure of the Judicial Panel on Multi-district Litigation states that the existence of a conditional transfer order “does not affect or suspend orders and pretrial proceedings in the district court in which the action is pending and does not in any way limit the pretrial jurisdiction of that сourt.” Thus, the court has jurisdiction to rule on plaintiffs motion.
B. Standard of Review
Although plaintiff has requested this court to remand the case, defendants bear the burden of proving that this court has subject matter jurisdiction because théy removed the case to federal court.
Tylka v. Gerber Products Co.,
Plaintiff argues that removаl of this case was improper for three reasons. First, there is no diversity jurisdiction in this case because the state of Wisconsin is the real party in interest. Second, the Eleventh Amendment bars removal of this case. Third, removal was improper because one of the defendants, Gensia Sicor Pharmaceuticals, did not file а timely consent to the notice of removal. I agree that the state of Wisconsin is the real party in interest and that this court does not have diversity jurisdiction over the case. Because my agreement with plaintiffs first argument is sufficient to decide this motion, I express no opinion on plaintiffs arguments regarding the Eleventh Amendment and failure to file a timely consent.
C. Real Party in Interest
The removal statute, 28 U.S.C. § 1441, states that “any civil action brought in a State court of which the district courts of the United States have original jurisdiction, may be removed by the defendant or the defendants, to the district court of the United States for the district and division embracing the place where such action is pending.” In its notice of removal, defendant Bayer Corporation alleged that this court had original jurisdiction over this case by way of diversity. Diversity jurisdiction requires that the parties be citizens of different states and the dispute between them exceed $75,000. 28 U.S.C. § 1332.
It is well settled that a state is not a citizen for diversity purposes.
Indiana Port Comm’n v. Bethlehem Steel
*1061
Corp.,
Defendants propose to split the claims in plaintiffs complaint into two groups: those brought on behalf of the state and those brought on behalf of private citizens and organizations in Wisconsin. Defendants concede that plaintiff has an interest in the claims brought on behalf оf the state but argue that with respect to the claims brought on behalf of private parties, those private parties are the true parties in interest because the relief requested will go directly to them. Therefore, defendants argue, the citizenship of those parties is relevant for diversity purposes. Defendants then argue that the claims brought on behalf of several large Wisconsin-based health insurers meet § 1332(a)(l)’s diversity and amount in controversy requirements. Thus, the court has diversity jurisdiction over those claims and supplemental jurisdiction over all other claims in plaintiffs complaint pursuant to 28 U.S.C. § 1367.
In support of their arguments, defendants cite
State of Connecticut v. Levi Strauss & Co.,
Plaintiff argues that this court should not apply the reasoning in
Levi Strauss
to this case. Plaintiff argues that it is the real party in interest in this case when the case is viewed as a whole. First, Counts I-IV in the complaint (the two consumer fraud claims, the secret rebates claim and the Medicaid fraud claim) are brought pursuant to the state’s law enforcement authority.
See
Wis. Stat. § 100.18(ll)(d) (authorizing Department of Justice
to
bring suit in name of state to enjoin violation of consumer fraud statute); § 133.16 (authorizing Department of Justicе to bring suit to prevent or restrain violations of antitrust statute); § 49.495 (giving Department of Justice authority to prosecute violations of laws affecting medical assistance programs). Second, a state is not stripped of its sovereignty merely because it seeks relief on behalf of its citizens in addition to
*1062
relief for harm done to thе state itself. In support of this argument, plaintiff cites
Moore v. Abbott Laboratories, Inc.,
In
Moore,
In
State of New York,
This conclusion is not altered by the State’s decision to seek restitutionary relief and damages on behalf of those who allegedly have been defrauded by GM. Recovery of damages for aggrieved consumers is but one aspect of the case. The focus is on obtaining wide-ranging injunctive relief designed to vindicate the State’s quasi-sovereign interest in securing an honest marketplace for all consumers. That recovery on behalf of an identifiable group is also sought should not require this Court to ignore the primary purpose of the action and to characterize it as one brought solely for the benefit of a few private parties.
Id. at 706-07.
In the present case, defendants’ arguments appear to rest on a basic misunderstanding of the court’s inquiry when faced with a real party in interest question. Defendants argue that the complaint should be split initially into two groups: claims made on behalf of private entities and claims made on behalf of the state. According to defendants, the court should then determine who is the real party in interest with respect to each group of claims. Defendants are correct that plaintiff appears to be wearing two hats by requesting relief for itself and for private parties, but that fact does not require this сourt to break the complaint apart along those lines for purposes of determining the real party in interest. On the contrary, most courts analyze real party in interest questions by examining the state’s interest in a lawsuit as a whole.
See Moore,
Defendants cite
Missouri, Kansas & Texas Railway Co. v. Hickman,
Thus, viеwing the complaint as a whole, I am persuaded that plaintiff has a “substantial stake” in the outcome of this case. Four of the five claims in this case were brought by the Attorney General pursuant to specific statutory authority.
See Moore,
D. Fees and Costs
Finally, plaintiff has asked for an award of attorney fees and costs incurred in seeking remand of this action. In this circuit, a party that sucсeeds in showing that removal is improper is presumptively entitled to an award of fees.
Garbie v. DaimlerChrysler Corp.,
Defendants have not addressed the award of fees and costs, presumably because they concentrated on establishing their right to removal. Now that I have found that defendants are not entitled to removal, it is necessary to consider whether there is any reason to deny plaintiff its fees and costs. If the question were one of goоd faith, this would be a more difficult case. Defendant’s arguments were not frivolous. However, in light of the presumption that awards should be made to the victorious party, I conclude that plaintiff is entitled to reimbursement for its reasonable fees and costs.
ORDER
IT IS ORDERED that
1. Plaintiffs motion to remand this case to state court is GRANTED.
2. Plaintiffs request for costs and аttorney fees under 28 U.S.C. § 1447(c) is GRANTED.
3. Plaintiff may have until October 20, 2004, in which to submit an itemization of the actual expenses, including costs and attorney fees, it incurred in responding to defendants’ removal.
4. Defendants may have until November 3, 2004, to file an objection to any itemized costs and fees.
5. This case is REMANDED to the Circuit Court for Dane County, Wisconsin.
6. The clerk of court is directed to return the record in case number 04-C-0477-C to the Circuit Court for Dane County, Wisconsin.
